|
FROM THE IW FORUMS
Honda Begins Production of Fuel Cell Car
"200
in 3 years of production? If that isn't a typo then it certainly is a
joke but just who is the joke on?"
Click to
continue
and discuss.
SEC OKs CEO's Anonymous Posts
"...hopefully the PR/AR risks of being 'uncovered' as a
sockpuppet will limit this practice even if regulators won't..."
Click to
continue
and discuss.
A Sure Sign That The Global Economy Is Going to S**t
"Would
you rather own... The world's largest investment bank [or] The world's
largest fertilizer maker..."
Click to
continue
and discuss.
What's Happening to Japanese Employees?
"...Japanese employees are willing to blow the whistle on
their companies -- something that has been unheard of in Japan.... Will
this strengthen or weaken the manufacturing sector in Japan?..."
Click to
continue
and discuss.
YOU WRITE THE
CAPTION
IndustryWeek's
"you write the caption" -- features drawings by award-winning
cartoonist Jerry
King. Please submit
your best caption for the cartoon below in the the
IndustryWeek forums.
The winning caption will be featured on the IndustryWeek Web
site and in
this newsletter.
WHAT'S GOING ON HERE?
Write the
caption
for this latest cartoon and read the other submissions.
See past winners at our winning
caption archive.
MANUFACTURING POLL
Has the high price
of gasoline caused your company to change any workforce HR
policies (e.g.,
shift changes, work from home, encourage
carpooling)?
-
Yes, we have already done so.
-
Not yet, but we are considering it.
-
No
Vote now at http://www.industryweek.com.
After you
have
voted, comment in the IW forums.
See our last poll results:
Have you increased the prices of your products as a result of
increased energy
costs?
|
FEATURED COLUMNS
The Competitive Edge -- Globalization Comes Under
Siege
A rising tide of anti-globalization sentiment could threaten
trade-dependent U.S. manufacturers.
By
Thomas J. Duesterberg
A few short years ago, Thomas Friedman crystallized both academic
studies and leading opinion about the inevitable advance of global
integration in his book The World Is Flat. More recently, no matter
where one turns, there is evidence of reaction against, and resistance
to, globalization. Is this just one of the periodic swings in public
opinion and political rhetoric (noted academics like Alan Blinder share
this view, too), or has the tide turned strongly enough to roll back the
changes of the last few decades? Given the current strength in U.S.
manufacturing exports and weakness of domestic demand, this is a crucial
question for industry leaders.
The signs of anti-globalization sentiment are legion, both here and
abroad:
- U.S. presidential candidates are calling for revising NAFTA and
halting further trade agreements;
- tainted toys, drugs and food imported from China and elsewhere have
revived fears of the safety and quality of imports;
- the accumulation of vast foreign currency holdings by "sovereign
wealth funds" is stoking fears of...
Click
to
continue.
Taking the NanoPulse -- The Nano-Doctor Is In
Take two nanotechnologies and call me in the
morning.
By
Scott E. Rickert
Nanotechnology and health. Seems that lately some alarmist pundits
would have you believe those two words don't belong in the same
sentence. I suggest we take another look into the microscope.
Nanotechnology is driving force behind some of the most innovative
medical treatments in the pipeline. These breakthroughs will have to
make their way to market through the complex maze and under the watchful
eyes of the Federal Drug Administration, Centers for Disease Control and
foundations chartered to fight disease. And well they should.
Nano-medicine innovations are being poked and probed by some of the best
doctors on the planet -- and showing remarkable promise. For some,
development may take up to 15 years. Believe me, they're worth watching
-- and waiting for. Others are already are already reality. There's good
news in diagnostics, treatments and prevention. Let's take a peak in the
doctor's bag.
What if we could stop treating a genetic disease, and simply "turning
off" the offending gene? That's the potential of nanotechnology from
Copernicus Therapeutics. They've been able to develop DNA nanoparticles
that are small enough pass through cell walls. They offer the potential
to replace defective genes, enable cells to create their own therapeutic
substances or "turn off" the problem genes. This technology has moved
far beyond theory. Cystic Fibrosis Foundation Therapeutics, Inc., a
non-profit affiliate of the Cystic Fibrosis Foundation has awarded
funding based on results in an animal model...
Click
to
continue.
UPCOMING CONFERENCES
7th Annual Compliance & Ethics Institute
Sunday,
September 14, 2008
Chicago
Produced by Society of Corporate Compliance & Ethics
Lean Accounting Summit
Wednesday, September 17, 2008
Las Vegas
Produced by Lean Accounting Summit
Plant-to-Enterprise Conference
Sunday,
September 21, 2008
Orlando
Produced by MESA International
UPCOMING
INDUSTRYWEEK WEBCASTS
PLEASE TAKE A QUICK
SURVEY
Take the Pulse of Global Manufacturing
IndustryWeek and TBM's LeanSigma Institute, a training and
education facility
of the TBM Consulting Group, have partnered to conduct a global
manufacturing
study to gain insight into current thinking about productivity,
innovation and
the economy. The survey should take approximately 5 minutes to
complete. To
thank you for your participation, we will send you an initial copy
of the study
results.
Click
here to participate in the survey.
|
